Fortive マネジメント
マネジメント 基準チェック /24
Fortiveの CEO はOlumide Soroyeで、 Jun2025年に任命され、 の在任期間は 1 年未満です。 の年間総報酬は$ 14.41Mで、 6.5%給与と93.5%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の0.085%を直接所有しており、その価値は$ 15.23M 。経営陣と取締役会の平均在任期間はそれぞれ1.3年と5.2年です。
主要情報
Olumide Soroye
最高経営責任者
US$14.4m
報酬総額
| CEO給与比率 | 6.47% |
| CEO在任期間 | less than a year |
| CEOの所有権 | 0.08% |
| 経営陣の平均在職期間 | 1.3yrs |
| 取締役会の平均在任期間 | 5.2yrs |
経営陣の近況
Recent updates
ナラティブの更新 • May 20
FTV: Buybacks And Sequential Execution Will Support Future Earnings Quality
Fortive's analyst price target has been raised by several firms in recent research, collectively edging higher by single digits in dollar terms. Analysts point to solid sequential growth and recent company execution to support slightly higher revenue growth and P/E expectations, even as profit margin assumptions are trimmed and the discount rate is nudged up.ナラティブの更新 • May 02
FTV: Sterilization Demand And Buybacks Will Support Future Earnings Quality
Fortive's analyst fair value estimate has been nudged up by $1 to $73 after analysts weighed a mix of recent price target increases and trims alongside recalibrated assumptions for growth, margins and future P/E levels. Analyst Commentary Recent Street research on Fortive shows a mix of target price trims and increases, with bullish analysts generally leaning toward higher fair value assumptions even as some recalibrate their models.
ナラティブの更新 • Apr 16
FTV: Future P E Compression Will Challenge Buyback Support At Current Levels
Fortive's analyst price targets have seen a mixed reset, with one firm trimming its view by $7 while several others lifted their targets by $4 to $9, as analysts factor in modest tweaks to fair value, discount rate, revenue growth, profit margin, and future P/E assumptions. Analyst Commentary Recent research on Fortive shows a mix of optimism and caution, with several firms lifting their price targets and one trimming its view by $7.Seeking Alpha • Apr 14
Fortive: Starting To Improve Its Performance
Summary Fortive has executed well post-Ralliant spin-off, delivering solid earnings and modest organic growth, supporting a fair valuation. Fortive's 2025 sales rose 2% to $4.16B, with 4Q organic growth exceeding 3%; adjusted EPS reached $2.71, up $0.30 YoY. Guidance targets 2026 adjusted EPS of $2.90–$3.00, underpinned by 2–3% organic growth, margin gains, and continued buybacks. At 19–20x forward earnings and leverage in the mid-2s, Fortive offers reasonable value, though upside is capped without stronger growth catalysts. Read the full article on Seeking Alphaナラティブの更新 • Apr 02
FTV: Fair Value View Balances Buybacks Against Execution And P E Compression Risks
Analysts have nudged their fair value estimate for Fortive higher to $52.50 from $51.10, reflecting updated views on revenue growth, margins, and future P/E assumptions following a mix of recent price target hikes and one downgrade across the Street. Analyst Commentary Recent Street research on Fortive shows a mixed but generally cautious tone, with a cluster of price target increases alongside at least one downgrade and a later price target cut.ナラティブの更新 • Mar 19
FTV: Fair Value Case Weighs Buybacks Against Execution And Multiple Compression Risks
Fortive's analyst price target has been adjusted slightly lower to $51.10. Analysts point to updated fair value estimates, refined discount rate assumptions, and refreshed views on revenue growth, margins, and future P/E multiples following a series of recent price target revisions across major firms.ナラティブの更新 • Mar 05
FTV: North American Sterilization Demand Will Support Future Earnings Quality Upside
Analysts have lifted their price targets on Fortive, supporting a move in our fair value estimate from $66.00 to $72.00. They cited updated expectations for revenue growth, profitability and a lower forward P/E multiple.
ナラティブの更新 • Feb 19
FTV: Recent Rating Shift And Buybacks Will Shape Future Return Profile
Our updated Fortive narrative reflects a higher implied price target of about $62, as analysts factor in steadier revenue growth assumptions, slightly stronger profit margins, a modestly lower discount rate, and a similar forward P/E, consistent with a series of recent price target increases across the Street. Analyst Commentary Recent Street research shows a cluster of higher Fortive price targets, alongside at least one downgrade.ナラティブの更新 • Feb 04
FTV: JPMorgan Downgrade And Buybacks Will Shape A Measured Return Profile
Analysts have trimmed their price target on Fortive to US$58.13, citing a slightly lower discount rate, modestly softer revenue expectations and a higher assumed profit margin supported by a reduced future P/E multiple. Analyst Commentary Recent commentary around the new US$58.13 price target reflects a mixed view on Fortive, with the latest JPMorgan downgrade underlining both execution opportunities and areas of concern for valuation and growth.ナラティブの更新 • Jan 21
FTV: Balanced Outlook As Healthcare Demand And Buybacks Shape Future Returns
Narrative Update The analyst price target for Fortive has shifted from approximately $56.13 to $58.13, as analysts cite recent model updates and sequential improvements in North American demand for sterilization and biomedical equipment, along with higher AHS adjusted EBITDA driven by gross profit growth and lower costs. Analyst Commentary Recent research on Fortive reflects a mix of optimism on execution and caution around upside potential, which is showing up in both price target changes and rating shifts.ナラティブの更新 • Jan 06
FTV: Fair Value View Balances Higher Demand With Margin Execution Risks
Analysts have increased their fair value estimate for Fortive from US$50.00 to US$52.00, citing refreshed models after the Q3 report and Street research that points to improved North American demand for sterilization and biomedical equipment, stronger AHS adjusted EBITDA margins, and updated price targets clustered around US$55 to US$58. Analyst Commentary Recent Street research on Fortive points to updated price targets clustered in the US$55 to US$58 range, with analysts revising their models following the Q3 report.分析記事 • Dec 27
Estimating The Fair Value Of Fortive Corporation (NYSE:FTV)
Key Insights The projected fair value for Fortive is US$53.12 based on 2 Stage Free Cash Flow to Equity Current share...ナラティブの更新 • Dec 15
FTV: North American Sterilization Demand Will Support Earnings Quality And Upside Potential
Analysts have modestly raised their blended price target on Fortive to about $58 per share from roughly $55, citing improved North American demand for sterilization and biomedical equipment, stronger margins in Advanced Healthcare Solutions, and updated post earnings financial models that still reflect slightly softer long term growth and profitability assumptions. Analyst Commentary Bullish analysts are pointing to a constructive risk reward profile for Fortive, highlighting that incremental execution gains and healthier end market trends can support the recent step up in valuation.ナラティブの更新 • Oct 20
Recurring Software Trends Will Secure Resilience Amid Tariff Uncertainty
Analysts have lowered their fair value estimate for Fortive to $56.13 from $57.25. They cite a tougher outlook and more challenging revenue growth projections for the remainder of the year.ナラティブの更新 • Sep 18
Recurring Software Trends Will Secure Resilience Amid Tariff Uncertainty
Analysts have lowered Fortive's price target to $57.25 due to skepticism over the company's ability to meet guidance amid slowing growth in its strongest segment, caution around macro headwinds post-Ralliant spinoff, and minimal near-term revenue growth. Analyst Commentary Persistent skepticism regarding Fortive's ability to achieve its full-year guidance following a cautious update and lack of supportive industry data.ナラティブの更新 • Sep 03
Recurring Software Trends Will Secure Resilience Amid Tariff Uncertainty
Analysts have lowered Fortive’s target price to $60.50, citing uncertainty about achieving updated guidance following the Ralliant spin-off, ongoing topline and margin pressures, and diminished visibility post-restructuring. Analyst Commentary Bullish analysts highlight Fortive's high earnings visibility and strong recurring revenue profile (~50%+), expecting portfolio reviews and strategic focus on workflow management software and healthcare to support margin resilience.分析記事 • May 30
A Look At The Intrinsic Value Of Fortive Corporation (NYSE:FTV)
Key Insights Fortive's estimated fair value is US$88.69 based on 2 Stage Free Cash Flow to Equity Fortive's US$71.07...Seeking Alpha • Mar 10
Fortive Seeing Signs Of Improvement, But Valuation Doesn't Make It An Easy Call
Summary Fortive's fourth-quarter results (and full 2024 results) showed fairly ordinary performance, with revenue and margins missing targets, and the business model didn't meaningfully outperform peers through the cycle. 2025 should be a better year, and I'd expect Fortive's businesses to recover ahead of more manufacturing and machinery-focused peers. The upcoming split of Precision Technologies into Ralliant may reduce complexity but is unlikely to significantly add or destroy value, but I can see potential strategic bidders for Tektronix. Despite cautious optimism for 2025, FTV's valuation doesn't justify a premium, given its inability to outgrow inflation and deliver superior full-cycle performance. Read the full article on Seeking AlphaSeeking Alpha • Dec 11
Fortive Corporation: Undervaluation And Stability Give It An Edge (Rating Upgrade)
Summary Fortive Corporation's product innovations and increased bookings, particularly in cloud-based solutions, support a recovery by 2025 despite macro uncertainties delaying short-term growth. The company’s strong cash flow, robust liquidity, and undervaluation compared to peers justify an upgrade to a "Buy" rating. Fortive's solid balance sheet, aggressive share repurchase policy, and stable cash flow position it well for superior medium-term returns. Read the full article on Seeking AlphaSeeking Alpha • Sep 22
Fortive: A Softer Performance Triggers A Separation
Summary Fortive is a solid conglomerate operating in three segments, focusing on intelligent operating solutions, precision technologies and healthcare solutions. After a softer performance of the precision technologies business this year, the company has announced plans to separate the business. The company trades at reasonable valuations and leverage, with a potential for higher valuation post-separation, expected to complete by Q4 2025. I recommend initiating positions in the $70s or high $60s, as the business separation may drive significant shareholder value. Read the full article on Seeking AlphaCEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Apr 03 2026 | n/a | n/a | US$557m |
| Dec 31 2025 | US$14m | US$932k | US$533m |
| Sep 26 2025 | n/a | n/a | US$885m |
| Jun 27 2025 | n/a | n/a | US$879m |
| Mar 28 2025 | n/a | n/a | US$388m |
| Dec 31 2024 | US$8m | US$764k | US$483m |
| Sep 27 2024 | n/a | n/a | US$555m |
| Jun 28 2024 | n/a | n/a | US$661m |
| Mar 29 2024 | n/a | n/a | US$900m |
| Dec 31 2023 | US$8m | US$750k | US$408m |
| Sep 29 2023 | n/a | n/a | US$828m |
| Jun 30 2023 | n/a | n/a | US$800m |
| Mar 31 2023 | n/a | n/a | US$764m |
| Dec 31 2022 | US$7m | US$750k | US$755m |
| Sep 30 2022 | n/a | n/a | US$696m |
| Jul 01 2022 | n/a | n/a | US$659m |
| Apr 01 2022 | n/a | n/a | US$650m |
| Dec 31 2021 | US$14m | US$274k | US$580m |
報酬と市場: Olumideの 総報酬 ($USD 14.41M ) は、 US市場 ($USD 14.80M ) の同様の規模の企業の平均とほぼ同じです。
報酬と収益: Olumideの報酬は過去 1 年間で 20% 以上増加しました。
CEO
Olumide Soroye (52 yo)
less than a year
在職期間
US$14,405,012
報酬
Mr. Olumide O. Soroye is President, CEO & Director of Fortive Corporation from June 28, 2025. Mr. Soroye serves as Indpendent Director of Verisk Analytics, Inc. since August 19 2022. He was President and C...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| President | less than a year | US$14.41m | 0.085% $ 15.2m | |
| Senior VP & CFO | 1.2yrs | US$21.41m | 0.045% $ 8.2m | |
| Senior VP & Chief Legal Officer | 10yrs | US$5.09m | 0.029% $ 5.2m | |
| Chief Accounting Officer | 6.6yrs | データなし | 0.023% $ 4.1m | |
| Senior VP & Chief Technology and Business System Officer | 1.2yrs | データなし | データなし | |
| Vice President of Investor Relations | no data | データなし | データなし | |
| Senior VP & Chief People Officer | less than a year | データなし | データなし | |
| President of Fluke & Group President of Connected Reliability Group (CRG) | no data | データなし | データなし | |
| President of Gordian and Group President of Facilities & Asset Lifecycle (FAL) Group | no data | データなし | データなし | |
| President of ASP & Group President of Infection Prevention Group (IPG) | 1.3yrs | データなし | データなし | |
| President of Provation & Group President of Healthcare Productivity and Quality (HPQ) Group | 1.3yrs | データなし | データなし | |
| Group President of Environmental | 1.3yrs | データなし | データなし |
1.3yrs
平均在職期間
52yo
平均年齢
経験豊富な経営陣: FTVの経営陣は 経験豊富 とはみなされません ( 1.3年の平均在職年数)。これは新しいチームを示唆しています。
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| President | less than a year | US$14.41m | 0.085% $ 15.2m | |
| Independent Director | 9.8yrs | US$346.73k | 0.0017% $ 300.5k | |
| Independent Director | 5.2yrs | US$322.42k | 0.013% $ 2.3m | |
| Independent Director | 7.3yrs | US$347.42k | 0.0014% $ 251.9k | |
| Independent Director | 3.3yrs | US$272.42k | 0.0015% $ 264.5k | |
| Independent Director | 4.3yrs | US$321.20k | 0.0028% $ 509.3k | |
| Independent Director | 5.4yrs | US$335.85k | 0.0014% $ 251.9k | |
| Independent Chair of the Board | 5.8yrs | US$544.87k | 0.0014% $ 251.9k | |
| Independent Director | 1.3yrs | US$332.42k | データなし |
5.2yrs
平均在職期間
60yo
平均年齢
経験豊富なボード: FTVの 取締役会 は 経験豊富 であると考えられます ( 5.2年の平均在任期間)。
企業分析と財務データの現状
| データ | 最終更新日（UTC時間） |
|---|---|
| 企業分析 | 2026/05/21 17:38 |
| 終値 | 2026/05/21 00:00 |
| 収益 | 2026/04/03 |
| 年間収益 | 2025/12/31 |
データソース
企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。
| パッケージ | データ | タイムフレーム | 米国ソース例 |
|---|---|---|---|
| 会社財務 | 10年 |
| |
| アナリストのコンセンサス予想 | +プラス3年 |
|
|
| 市場価格 | 30年 |
| |
| 所有権 | 10年 |
| |
| マネジメント | 10年 |
| |
| 主な進展 | 10年 |
|
* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。
特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。
分析モデルとスノーフレーク
本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。
シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。
業界およびセクターの指標
私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。
アナリスト筋
Fortive Corporation 15 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。29
| アナリスト | 機関 |
|---|---|
| John Eade | Argus Research Company |
| Robert Mason | Baird |
| Quinn Fredrickson | Baird |